2[4]Prcusser P Wilke H, Achterrath W, et al.Phase Ⅱ study with the combination etoposide, doxorubicin, and cispatin in advanced measurable gatrie cancer[J]. J Clin Oncol,1989,7(9):1310～1317.
3[5]De Gramont A, Bosset JF, Milan C, et al.Randomized trial compa ring monthly low-dose leucovorin and fluorouracil bolux with bimonthly high-dose leacovorin and fluorouracil bolus plus continuous infusion for advanced colore ctal cancer:a French intergroup study[J].J Clin Oncol,1997,15(2):808～815.
4[6]Shiraska T,Aiba k,Araki H,et al.Combination therapy of continu ous venous infusion(CV1)of 5-Fu and low dose consecutive cisplatin(CDDP),and the new oral anti-cancer durg S-1 for advanced gastro-intestinal cancer[J].Can To Kagaku Ryoho,1999,26(4):456～466.
5[7]Machover D,Goldschmidt E,Schwarzenbergl,et al.Treatment of adv a nced colorectal and gastric adenocarcinomas with 5-Fu-orouracil combined with high-dose folinic acid.Au update[J].Chemioterapia,1985,4(5):369～376.
6[8]Cvitkovic E.A historical perspective on oxaliplation:rethinking the role of platinum compounds and learning from near misses[J].Semin Oncol,199 8,25(2 Suppl 5):1～3.
7[9]Ducreux M,Louvet C,Bekradda M,et al.Oxaliplation for the treat ment of advanced colorectal cancer:future directions[J].Semin Oncol,1998,25(2 Suppl 5):45～53.
4[2]The Meta - analysis Group in Cancer.Efficacy of continuous infusion of fiuorouracil compared with bolus administration in advanced colorectal cancer[J].J Clin Oncol,1998,16:301 ～ 308.
8LouvetC,AndreT,TigaudJM,et al.PhaseⅡ study of oxalicpiatin,fluorouracil,and folinic acid in locally advanced or metastatic gastril cancer patients[J].J Clin Oncol,2002,20 (23):4543 ～4548.
9KimDY,KimJH,LeeSH,et al.Phase Ⅱ study of oxaliplatin.5 -fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer[J].Ann Oncol,2003,14(3):383 ～ 387.
10SumpterKA,Harper-WynneC,CunninghamD,et al.Ran -domised,multicenter phase Ⅲ study comparing capecitabint with 5Fu and oxaliplatin with cisplatinin patients with advanced oesophagogastric cancer:Confirmation of dose escalation[J].Proc Am Soc Clin Oncol,2003,22:257.
